These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6347596)

  • 1. Third-generation and investigational cephalosporins: I. Structure-activity relationships and pharmacokinetic review.
    Garzone P; Lyon J; Yu VL
    Drug Intell Clin Pharm; 1983; 17(7-8):507-15. PubMed ID: 6347596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria.
    Jones RN; Erwin ME; Bale M
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):73-80. PubMed ID: 1580897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
    Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
    Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
    Marsh TD
    Infect Control; 1985 Feb; 6(2):78-83. PubMed ID: 3882594
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacokinetics of the third generation cephalosporins.
    Balant L; Dayer P; Auckenthaler R
    Clin Pharmacokinet; 1985; 10(2):101-43. PubMed ID: 3888488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third generation cephalosporins.
    Donowitz GR
    Infect Dis Clin North Am; 1989 Sep; 3(3):595-612. PubMed ID: 2671141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current state of cephalosporin antibiotics: microbiological aspects.
    Knothe H; Dette GA
    Infection; 1983; 11 Suppl 1():S12-5. PubMed ID: 6601063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
    Neu HC
    Annu Rev Pharmacol Toxicol; 1982; 22():599-642. PubMed ID: 6282190
    [No Abstract]   [Full Text] [Related]  

  • 11. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
    Garzone P; Lyon J; Yu VL
    Drug Intell Clin Pharm; 1983 Sep; 17(9):615-22. PubMed ID: 6311502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of newer cephalosporins into cerebrospinal fluid.
    Cherubin CE; Eng RH; Norrby R; Modai J; Humbert G; Overturf G
    Rev Infect Dis; 1989; 11(4):526-48. PubMed ID: 2672238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
    van Klingeren B
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
    Norris SM; Guenthner SH; Wenzel RP
    J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.
    Brogden RN; Carmine A; Heel RC; Morley PA; Speight TM; Avery GS
    Drugs; 1981 Dec; 22(6):423-60. PubMed ID: 6459224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of antibacterial activities of cephalosporins].
    Kayser FH; Kohler ML
    Schweiz Med Wochenschr; 1984 Feb; 114(5):156-61. PubMed ID: 6701496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
    Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
    G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.